KAPUALabs - Nova (Page 272)

Examining Meta's diversification into messaging, social commerce, hardware, and subscriptions amid regulatory hurdles.

By KAPUALabs

/ 19 Jun 2026

Retatrutide's early data and AI efficiencies support a bullish case, but Zepbound's legal challenges inject uncertainty.

By KAPUALabs

/ 19 Jun 2026

Thousands forced to train replacements while facing layoffs; internal dissent threatens Meta's AI transformation.

By KAPUALabs

/ 19 Jun 2026

From open-source LLMs to smart glasses, Meta's pivot carries execution, trust, and regulatory perils.

By KAPUALabs

/ 19 Jun 2026

Examining the convergence of GDPR, DMA, DSA, and antitrust actions reshaping Meta's business model.

By KAPUALabs

/ 19 Jun 2026

An institutional analysis of Meta's forced exit from VR, massive layoffs, and aggressive AI infrastructure buildout.

By KAPUALabs

/ 19 Jun 2026

While retail flees, insiders and institutions see a 18x P/E and a strong buy consensus as too compelling to ignore.

By KAPUALabs

/ 19 Jun 2026

How Instagram Plus, Facebook Plus, and WhatsApp Plus reshape Meta's revenue model and competitive moat.

By KAPUALabs

/ 19 Jun 2026

Alleged scheme exploited PBM rebates through secondary-market sales, exposing material financial exposure for Lilly's top-selling drug.

By KAPUALabs

/ 19 Jun 2026

An in-depth look at Meta's strategic pivot from 8,000 layoffs to a $20 billion subscription bet and massive AI investments.

By KAPUALabs

/ 19 Jun 2026

From 1 billion Meta AI users to automated code reviews, artificial intelligence is rewriting Meta's growth story and competitive moat.

By KAPUALabs

/ 19 Jun 2026

A comprehensive analysis of Meta's Q1 2026 beat, AI-driven margin expansion, and the valuation paradox underlying robust fundamentals.

By KAPUALabs

/ 19 Jun 2026